85446-05-5Relevant articles and documents
Carbazole compound and application thereof in preparation of medicines for treating fatty liver and 2 type diabetes and other metabolic related diseases
-
Paragraph 0072-0075, (2021/09/21)
The invention relates to a carbazole compound and application thereof in preparation of drugs for treating metabolic related diseases such as fatty liver and 2 type diabetes, wherein the structural general formula of the carbazole compound is as shown in
With chiral center carbazolyl isopropanolamine derivatives of the preparation method and application of (by machine translation)
-
Paragraph 0056; 0057; 0062; 0067, (2019/05/04)
The invention relates to a with chiral center carbazolyl isopropanolamine derivatives of the preparation method and application. This compound has the general formula (I) indicated by the structure: The compound such as [...] Phaeosphaeria, tobacco wilt b
Potential Antimicrobial Isopropanol-Conjugated Carbazole Azoles as Dual Targeting Inhibitors of Enterococcus faecalis
Zhang, Yuan,Tangadanchu, Vijai Kumar Reddy,Cheng, Yu,Yang, Ren-Guo,Lin, Jian-Mei,Zhou, Cheng-He
supporting information, p. 244 - 249 (2018/03/21)
A series of isopropanol-bridged carbazole azoles as potential antimicrobial agents were designed and synthesized from commercial carbazoles. Bioassay revealed that 3,6-dichlorocarbazolyl triazole 3f could effectively inhibit the growth of E. faecalis with minimal inhibitory concentration of 2 μg/mL. The active molecule 3f showed lower propensity to trigger the development of resistance in bacteria than norfloxacin and exerted rapidly bactericidal ability. Compound 3f also exhibited low cytotoxicity to normal mammalian RAW264.7 cells. Further mechanism exploration indicated that conjugate 3f was membrane active against E. faecalis and could form 3f-DNA complex by intercalating into DNA of resistant E. faecalis, which might be responsible for its antimicrobial action. Molecular docking showed an efficient binding of triazole derivative 3f with DNA gyrase enzyme through noncovalent interactions.